BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 32463297)

  • 21. IL-6 and PD-L1 antibody blockade combination therapy reduces tumour progression in murine models of pancreatic cancer.
    Mace TA; Shakya R; Pitarresi JR; Swanson B; McQuinn CW; Loftus S; Nordquist E; Cruz-Monserrate Z; Yu L; Young G; Zhong X; Zimmers TA; Ostrowski MC; Ludwig T; Bloomston M; Bekaii-Saab T; Lesinski GB
    Gut; 2018 Feb; 67(2):320-332. PubMed ID: 27797936
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Modulation of Cancer-Associated Fibrotic Stroma by An Integrin α
    Turaga RC; Sharma M; Mishra F; Krasinskas A; Yuan Y; Yang JJ; Wang S; Liu C; Li S; Liu ZR
    Cell Mol Gastroenterol Hepatol; 2021; 11(1):161-179. PubMed ID: 32810598
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Desmoplasia suppression by metformin-mediated AMPK activation inhibits pancreatic cancer progression.
    Duan W; Chen K; Jiang Z; Chen X; Sun L; Li J; Lei J; Xu Q; Ma J; Li X; Han L; Wang Z; Wu Z; Wang F; Wu E; Ma Q; Ma Z
    Cancer Lett; 2017 Jan; 385():225-233. PubMed ID: 27773749
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Krüppel-like Factor 5, Increased in Pancreatic Ductal Adenocarcinoma, Promotes Proliferation, Acinar-to-Ductal Metaplasia, Pancreatic Intraepithelial Neoplasia, and Tumor Growth in Mice.
    He P; Yang JW; Yang VW; Bialkowska AB
    Gastroenterology; 2018 Apr; 154(5):1494-1508.e13. PubMed ID: 29248441
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fatty Acid-Mediated Stromal Reprogramming of Pancreatic Stellate Cells Induces Inflammation and Fibrosis That Fuels Pancreatic Cancer.
    Hata T; Kawamoto K; Eguchi H; Kamada Y; Takamatsu S; Maekawa T; Nagaoka S; Yamada D; Iwagami Y; Asaoka T; Noda T; Wada H; Gotoh K; Masamune A; Miyoshi E; Mori M; Doki Y
    Pancreas; 2017; 46(10):1259-1266. PubMed ID: 28991878
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Regulation of pH by Carbonic Anhydrase 9 Mediates Survival of Pancreatic Cancer Cells With Activated KRAS in Response to Hypoxia.
    McDonald PC; Chafe SC; Brown WS; Saberi S; Swayampakula M; Venkateswaran G; Nemirovsky O; Gillespie JA; Karasinska JM; Kalloger SE; Supuran CT; Schaeffer DF; Bashashati A; Shah SP; Topham JT; Yapp DT; Li J; Renouf DJ; Stanger BZ; Dedhar S
    Gastroenterology; 2019 Sep; 157(3):823-837. PubMed ID: 31078621
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pancreatic stellate cells and pancreas cancer: current perspectives and future strategies.
    Haqq J; Howells LM; Garcea G; Metcalfe MS; Steward WP; Dennison AR
    Eur J Cancer; 2014 Oct; 50(15):2570-82. PubMed ID: 25091797
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of pancreatic stellate cells and periostin in pancreatic cancer progression.
    Liu Y; Du L
    Tumour Biol; 2015 May; 36(5):3171-7. PubMed ID: 25840689
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sauchinone inhibits hypoxia-induced epithelial-mesenchymal transition in pancreatic ductal adenocarcinoma cells through the Wnt/β-catenin pathway.
    Qiao Y; Yan LJ; Yan C
    Anticancer Drugs; 2020 Oct; 31(9):918-924. PubMed ID: 32889895
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pirfenidone inhibits pancreatic cancer desmoplasia by regulating stellate cells.
    Kozono S; Ohuchida K; Eguchi D; Ikenaga N; Fujiwara K; Cui L; Mizumoto K; Tanaka M
    Cancer Res; 2013 Apr; 73(7):2345-56. PubMed ID: 23348422
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact of the secretome of activated pancreatic stellate cells on growth and differentiation of pancreatic tumour cells.
    Marzoq AJ; Mustafa SA; Heidrich L; Hoheisel JD; Alhamdani MSS
    Sci Rep; 2019 Mar; 9(1):5303. PubMed ID: 30923340
    [TBL] [Abstract][Full Text] [Related]  

  • 32. α-Mangostin inhibits hypoxia-driven ROS-induced PSC activation and pancreatic cancer cell invasion.
    Lei J; Huo X; Duan W; Xu Q; Li R; Ma J; Li X; Han L; Li W; Sun H; Wu E; Ma Q
    Cancer Lett; 2014 May; 347(1):129-38. PubMed ID: 24513179
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Therapeutic Strategies Toward Lactate Dehydrogenase Within the Tumor Microenvironment of Pancreatic Cancer.
    Moir JAG; Long A; Haugk B; French JJ; Charnley RM; Manas DM; Wedge SR; Mann J; Robinson SM; White SA
    Pancreas; 2020; 49(10):1364-1371. PubMed ID: 33122526
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The P2X7 Receptor Stimulates IL-6 Release from Pancreatic Stellate Cells and Tocilizumab Prevents Activation of STAT3 in Pancreatic Cancer Cells.
    Magni L; Bouazzi R; Heredero Olmedilla H; Petersen PSS; Tozzi M; Novak I
    Cells; 2021 Jul; 10(8):. PubMed ID: 34440697
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pancreatic stellate cells activated by mutant KRAS-mediated PAI-1 upregulation foster pancreatic cancer progression via IL-8.
    Wang HC; Lin YL; Hsu CC; Chao YJ; Hou YC; Chiu TJ; Huang PH; Tang MJ; Chen LT; Shan YS
    Theranostics; 2019; 9(24):7168-7183. PubMed ID: 31695760
    [No Abstract]   [Full Text] [Related]  

  • 36. Inhibiting YAP expression suppresses pancreatic cancer progression by disrupting tumor-stromal interactions.
    Jiang Z; Zhou C; Cheng L; Yan B; Chen K; Chen X; Zong L; Lei J; Duan W; Xu Q; Li X; Wang Z; Ma Q; Ma J
    J Exp Clin Cancer Res; 2018 Mar; 37(1):69. PubMed ID: 29587800
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Indometacin inhibits the proliferation and activation of human pancreatic stellate cells through the downregulation of COX-2.
    Sun L; Chen K; Jiang Z; Chen X; Ma J; Ma Q; Duan W
    Oncol Rep; 2018 May; 39(5):2243-2251. PubMed ID: 29565462
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cancer-stellate cell interactions perpetuate the hypoxia-fibrosis cycle in pancreatic ductal adenocarcinoma.
    Erkan M; Reiser-Erkan C; Michalski CW; Deucker S; Sauliunaite D; Streit S; Esposito I; Friess H; Kleeff J
    Neoplasia; 2009 May; 11(5):497-508. PubMed ID: 19412434
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Activated leukocyte cell adhesion molecule regulates the interaction between pancreatic cancer cells and stellate cells.
    Zhang WW; Zhan SH; Geng CX; Sun X; Erkan M; Kleeff J; Xie XJ
    Mol Med Rep; 2016 Oct; 14(4):3627-33. PubMed ID: 27573419
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Metformin suppresses tumor angiogenesis and enhances the chemosensitivity of gemcitabine in a genetically engineered mouse model of pancreatic cancer.
    Qian W; Li J; Chen K; Jiang Z; Cheng L; Zhou C; Yan B; Cao J; Ma Q; Duan W
    Life Sci; 2018 Sep; 208():253-261. PubMed ID: 30053447
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.